The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Psychiatric Complications with Chloroquine and Quinacrine

Published Online:https://doi.org/10.1176/ajp.124.9.1257

Quinacrine and chloroquine are being used increasingly in the United States in the treatment of malaria and as an anti-inflammatory agent. In the two cases reported here, quinacrine was administered within the normal therapeutic range and toxic psychoses resulted. Chloroquine produces similar conditions. The author predicts an increase in the complications of suicide, malingering, and toxic psychoses associated with the increasing use of the two drugs.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.